Triumeq, a fixed-dose combination medication primarily used to treat HIV-1, has significantly impacted the pharmaceutical market since its introduction. The drug contains three active ingredients: dolutegravir, abacavir, and lamivudine. Each of these components works synergistically to inhibit the replication of the HIV virus, thereby managing the disease more effectively. The...
Chinese
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek